Publikasi Scopus 2010 s/d 2022

Gondhowiardjo S.A., Adham M., Rachmadi L., Atmakusuma T.D., Tobing D.L., Auzan M., Hariyanto A.D., Sulaeman D., Permata T.B.M., Handoko
6508327402;14024202100;55062422000;23472246000;57208108576;57214757319;57253039400;57202448631;57197808751;57209984822;
Immune cells markers within local tumor microenvironment are associated with EBV oncoprotein in nasopharyngeal cancer
2022
BMC Cancer
22
1
887
1
Department of Radiation Oncology, Faculty of Medicine, Universitas Indonesia / Cipto Mangunkusumo National General Hospital, Jakarta – Indonesia, Jl. Salemba Raya No. 6, Jakarta, 10430, Indonesia; Department of ENT, Faculty of Medicine, Universitas Indonesia / Cipto Mangunkusumo National General Hospital, Jakarta – Indonesia, Jl. Salemba Raya No. 6, Jakarta, 10430, Indonesia; Department of Anatomical Pathology, Faculty of Medicine, Universitas Indonesia / Cipto Mangunkusumo National General Hospital, Jakarta – Indonesia, Jl. Salemba Raya No. 6, Jakarta, 10430, Indonesia; Department of Medical Oncology, Faculty of Medicine, Universitas Indonesia / Cipto Mangunkusumo National General Hospital, Jakarta – Indonesia, Jl. Salemba Raya No. 6, Jakarta, 10430, Indonesia; Department of Clinical Pathology, Dharmais National Cancer Hospital, Jakarta – Indonesia, Jl. Letjen S. Parman No. 84-86, Jakarta, 11420, Indonesia
Gondhowiardjo, S.A., Department of Radiation Oncology, Faculty of Medicine, Universitas Indonesia / Cipto Mangunkusumo National General Hospital, Jakarta – Indonesia, Jl. Salemba Raya No. 6, Jakarta, 10430, Indonesia; Adham, M., Department of ENT, Faculty of Medicine, Universitas Indonesia / Cipto Mangunkusumo National General Hospital, Jakarta – Indonesia, Jl. Salemba Raya No. 6, Jakarta, 10430, Indonesia; Rachmadi, L., Department of Anatomical Pathology, Faculty of Medicine, Universitas Indonesia / Cipto Mangunkusumo National General Hospital, Jakarta – Indonesia, Jl. Salemba Raya No. 6, Jakarta, 10430, Indonesia; Atmakusuma, T.D., Department of Medical Oncology, Faculty of Medicine, Universitas Indonesia / Cipto Mangunkusumo National General Hospital, Jakarta – Indonesia, Jl. Salemba Raya No. 6, Jakarta, 10430, Indonesia; Tobing, D.L., Department of Clinical Pathology, Dharmais National Cancer Hospital, Jakarta – Indonesia, Jl. Letjen S. Parman No. 84-86, Jakarta, 11420, Indonesia; Auzan, M., Department of Radiation Oncology, Faculty of Medicine, Universitas Indonesia / Cipto Mangunkusumo National General Hospital, Jakarta – Indonesia, Jl. Salemba Raya No. 6, Jakarta, 10430, Indonesia; Hariyanto, A.D., Department of Radiation Oncology, Faculty of Medicine, Universitas Indonesia / Cipto Mangunkusumo National General Hospital, Jakarta – Indonesia, Jl. Salemba Raya No. 6, Jakarta, 10430, Indonesia; Sulaeman, D., Department of Radiation Oncology, Faculty of Medicine, Universitas Indonesia / Cipto Mangunkusumo National General Hospital, Jakarta – Indonesia, Jl. Salemba Raya No. 6, Jakarta, 10430, Indonesia; Permata, T.B.M., Department of Radiation Oncology, Faculty of Medicine, Universitas Indonesia / Cipto Mangunkusumo National General Hospital, Jakarta – Indonesia, Jl. Salemba Raya No. 6, Jakarta, 10430, Indonesia; Handoko, Department of Radiation Oncology, Faculty of Medicine, Universitas Indonesia / Cipto Mangunkusumo National General Hospital, Jakarta – Indonesia, Jl. Salemba Raya No. 6, Jakarta, 10430, Indonesia
Introduction: EBV infection in nasopharyngeal cancer ensued in latent infection mode. In this latent infection various EBV oncoproteins such as EBNA1 and LMP1 was expressed. EBV oncoproteins could theoretically recruit immune cells, which might help to control cancer. Therefore, this study was aimed to elucidate the association with EBV oncoproteins (EBNA1 and LMP1), immune markers (CD4, CD8, and FOXP3) from nasopharyngeal cancer microenvironment with tumor progression. Method: Nasopharyngeal biopsy was obtained from patients suspected to have nasopharyngeal cancer. Those samples with microscopically confirmed nasopharyngeal cancer were tested for EBNA1, LMP1, CD4, CD8, and FOXP3 concentration with ELISA, then verified with IHC. Each patient tumor volume was assessed for primary nasopharyngeal tumor volume (GTVp) and neck nodal metastases tumor volume (GTVn). Correlation test with Spearman correlation and scatterplot were carried out. Result: Total 23 samples with nasopharyngeal cancer were analyzed. There was moderate correlation (ρ = 0.45; p value = 0.032) between LMP1 and GTVp. There was strong correlation (ρ = 0.81; p value < 0.001) between CD8 and GTVp. There was also moderate correlation (ρ = 0.6; p value = 0.002) between FOXP3 and GTVp. The CD8 concentration has moderate correlation with both EBNA1 (ρ = 0.46; p value = 0.026) and LMP1 (ρ = 0.47; p value = 0.023). While FOXP3 has moderate correlation with only LMP1 (ρ = 0.58; p value = 0.004). No correlation was found between all the markers tested here with GTVn. Discussion: We found larger primary nasopharyngeal tumor was associated with higher CD8 marker. This was thought due to the presence of abundance CD8 T cells in the nasopharynx, but those abundance CD8 T cells were suspected to be dysfunctional. The nasopharyngeal cancer was also known to upregulate chemokines that could recruit T regulatory FOXP3 cells. Furthermore, T regulatory FOXP3 cells differentiation was induced through several pathways which was triggered by EBNA1. The correlation found in this study could guide further study to understand nasopharyngeal carcinogenesis and the relationship with our immune system. © 2022, The Author(s).
EBV oncoproteins; Immune markers; Microenvironment; Nasopharyngeal cancer; Tumor progression
Epstein Barr virus antigen; Epstein Barr virus antigen 1; LMP1 protein; oncoprotein; transcription factor FOXP3; unclassified drug; biological marker; forkhead transcription factor; matrix protein; oncoprotein; adult; Article; biopsy; carcinogenesis; CD4+ T lymphocyte; CD8+ T lymphocyte; clinical article; controlled study; correlation coefficient; disease association; enzyme linked immunosorbent assay; Epstein Barr virus; female; human; human cell; human tissue; immunocompetent cell; immunohistochemistry; male; nasopharyngeal biopsy; nasopharynx cancer; neck nodal metastasis tumor volume; primary nasopharyngeal tumor volume; tumor microenvironment; tumor volume; carcinoma; complication; Epstein Barr virus; Epstein Barr virus infection; infection; metabolism; nasopharynx carcinoma; nasophar
Universitas Indonesia
The authors would like to thank Ferdinand Maubere, MD for his assistance in designing the lovely figures in this paper. The authors also would like to thank Amelia Fossetta Manatar, MD for her assistance in facilitating IHC examination. All authors disclose no conflict of interest.
We received funding from Universitas Indonesia Research Grant, International Indexed Publication (PUTI) program 2020 with contract number BA-601/UN2.RST/PPM.00.03.01/2021. The funder has no influence on the design of the study and collection, analysis, an
BioMed Central Ltd
14712407
35963999
Article
Q2
1134
3336